The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Artificial Heart-Global Market Insights and Sales Trends 2025
Synopsis
Artificial hearts are being used to help patients with total heart failure live normal lives past their life expectancy time line, or to help patients survive until their transplant date either by replacing the heart completely or by replacing the ventricles. The device is surgically implanted in the chest in order to help in the functioning of a deteriorating heart. An artificial heart may also be used temporarily and is removed once the heart starts functioning normally. In cases where the damage is severe, the biological heart is completely replaced with the artificial heart. An artificial heart is powered by either compressed air or electricity.
The global Artificial Heart market size is expected to reach US$ 48 million by 2029, growing at a CAGR of 3.1% from 2023 to 2029. The market is mainly driven by the significant applications of Artificial Heart in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Artificial Heart market. Ventricular Assist Device (VAD), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Total Artificial Heart segment is estimated at % CAGR for the next seven-year period.
The rise in the number of cardiac disorders along with an increase in the geriatric population is anticipated to drive the artificial heart market in the coming years. Improper lifestyle, leading to deteriorating cardiac condition is expected to offer growth opportunities during the forecast period for the manufacturers of artificial heart.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Artificial Heart, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Artificial Heart market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Artificial Heart market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Artificial Heart sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Artificial Heart covered in this report include SynCardia Systems, BiVACOR, CARMAT, Abbott, Cleveland Heart, AbioMed, Jarvik Heart, MyLVAD and Cirtec Medical Systems, etc.
The global Artificial Heart market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
SynCardia Systems
BiVACOR
CARMAT
Abbott
Cleveland Heart
AbioMed
Jarvik Heart
MyLVAD
Cirtec Medical Systems
Thoratec Corporation
Global Artificial Heart market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Artificial Heart market, Segment by Type:
Ventricular Assist Device (VAD)
Total Artificial Heart
Global Artificial Heart market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Artificial Heart manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Artificial Heart in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Artificial hearts are being used to help patients with total heart failure live normal lives past their life expectancy time line, or to help patients survive until their transplant date either by replacing the heart completely or by replacing the ventricles. The device is surgically implanted in the chest in order to help in the functioning of a deteriorating heart. An artificial heart may also be used temporarily and is removed once the heart starts functioning normally. In cases where the damage is severe, the biological heart is completely replaced with the artificial heart. An artificial heart is powered by either compressed air or electricity.
The global Artificial Heart market size is expected to reach US$ 48 million by 2029, growing at a CAGR of 3.1% from 2023 to 2029. The market is mainly driven by the significant applications of Artificial Heart in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Artificial Heart market. Ventricular Assist Device (VAD), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Total Artificial Heart segment is estimated at % CAGR for the next seven-year period.
The rise in the number of cardiac disorders along with an increase in the geriatric population is anticipated to drive the artificial heart market in the coming years. Improper lifestyle, leading to deteriorating cardiac condition is expected to offer growth opportunities during the forecast period for the manufacturers of artificial heart.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Artificial Heart, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Artificial Heart market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Artificial Heart market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Artificial Heart sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Artificial Heart covered in this report include SynCardia Systems, BiVACOR, CARMAT, Abbott, Cleveland Heart, AbioMed, Jarvik Heart, MyLVAD and Cirtec Medical Systems, etc.
The global Artificial Heart market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
SynCardia Systems
BiVACOR
CARMAT
Abbott
Cleveland Heart
AbioMed
Jarvik Heart
MyLVAD
Cirtec Medical Systems
Thoratec Corporation
Global Artificial Heart market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Artificial Heart market, Segment by Type:
Ventricular Assist Device (VAD)
Total Artificial Heart
Global Artificial Heart market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Artificial Heart manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Artificial Heart in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Artificial Heart Market Overview
1.1 Artificial Heart Product Overview
1.2 Artificial Heart Market Segment by Type
1.2.1 Ventricular Assist Device (VAD)
1.2.2 Total Artificial Heart
1.3 Global Artificial Heart Market Size by Type
1.3.1 Global Artificial Heart Market Size Overview by Type (2018-2029)
1.3.2 Global Artificial Heart Historic Market Size Review by Type (2018-2023)
1.3.3 Global Artificial Heart Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Artificial Heart Sales Breakdown by Type (2018-2023)
1.4.2 Europe Artificial Heart Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Artificial Heart Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Artificial Heart Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Artificial Heart Sales Breakdown by Type (2018-2023)
2 Global Artificial Heart Market Competition by Company
2.1 Global Top Players by Artificial Heart Sales (2018-2023)
2.2 Global Top Players by Artificial Heart Revenue (2018-2023)
2.3 Global Top Players by Artificial Heart Price (2018-2023)
2.4 Global Top Manufacturers Artificial Heart Manufacturing Base Distribution, Sales Area, Product Type
2.5 Artificial Heart Market Competitive Situation and Trends
2.5.1 Artificial Heart Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Artificial Heart Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Artificial Heart as of 2022)
2.7 Date of Key Manufacturers Enter into Artificial Heart Market
2.8 Key Manufacturers Artificial Heart Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Artificial Heart Status and Outlook by Region
3.1 Global Artificial Heart Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Artificial Heart Historic Market Size by Region
3.2.1 Global Artificial Heart Sales in Volume by Region (2018-2023)
3.2.2 Global Artificial Heart Sales in Value by Region (2018-2023)
3.2.3 Global Artificial Heart Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Artificial Heart Forecasted Market Size by Region
3.3.1 Global Artificial Heart Sales in Volume by Region (2024-2029)
3.3.2 Global Artificial Heart Sales in Value by Region (2024-2029)
3.3.3 Global Artificial Heart Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Artificial Heart by Application
4.1 Artificial Heart Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Artificial Heart Market Size by Application
4.2.1 Global Artificial Heart Market Size Overview by Application (2018-2029)
4.2.2 Global Artificial Heart Historic Market Size Review by Application (2018-2023)
4.2.3 Global Artificial Heart Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Artificial Heart Sales Breakdown by Application (2018-2023)
4.3.2 Europe Artificial Heart Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Artificial Heart Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Artificial Heart Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Artificial Heart Sales Breakdown by Application (2018-2023)
5 North America Artificial Heart by Country
5.1 North America Artificial Heart Historic Market Size by Country
5.1.1 North America Artificial Heart Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Artificial Heart Sales in Volume by Country (2018-2023)
5.1.3 North America Artificial Heart Sales in Value by Country (2018-2023)
5.2 North America Artificial Heart Forecasted Market Size by Country
5.2.1 North America Artificial Heart Sales in Volume by Country (2024-2029)
5.2.2 North America Artificial Heart Sales in Value by Country (2024-2029)
6 Europe Artificial Heart by Country
6.1 Europe Artificial Heart Historic Market Size by Country
6.1.1 Europe Artificial Heart Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Artificial Heart Sales in Volume by Country (2018-2023)
6.1.3 Europe Artificial Heart Sales in Value by Country (2018-2023)
6.2 Europe Artificial Heart Forecasted Market Size by Country
6.2.1 Europe Artificial Heart Sales in Volume by Country (2024-2029)
6.2.2 Europe Artificial Heart Sales in Value by Country (2024-2029)
7 Asia-Pacific Artificial Heart by Region
7.1 Asia-Pacific Artificial Heart Historic Market Size by Region
7.1.1 Asia-Pacific Artificial Heart Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Artificial Heart Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Artificial Heart Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Artificial Heart Forecasted Market Size by Region
7.2.1 Asia-Pacific Artificial Heart Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Artificial Heart Sales in Value by Region (2024-2029)
8 Latin America Artificial Heart by Country
8.1 Latin America Artificial Heart Historic Market Size by Country
8.1.1 Latin America Artificial Heart Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Artificial Heart Sales in Volume by Country (2018-2023)
8.1.3 Latin America Artificial Heart Sales in Value by Country (2018-2023)
8.2 Latin America Artificial Heart Forecasted Market Size by Country
8.2.1 Latin America Artificial Heart Sales in Volume by Country (2024-2029)
8.2.2 Latin America Artificial Heart Sales in Value by Country (2024-2029)
9 Middle East and Africa Artificial Heart by Country
9.1 Middle East and Africa Artificial Heart Historic Market Size by Country
9.1.1 Middle East and Africa Artificial Heart Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Artificial Heart Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Artificial Heart Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Artificial Heart Forecasted Market Size by Country
9.2.1 Middle East and Africa Artificial Heart Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Artificial Heart Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 SynCardia Systems
10.1.1 SynCardia Systems Company Information
10.1.2 SynCardia Systems Introduction and Business Overview
10.1.3 SynCardia Systems Artificial Heart Sales, Revenue and Gross Margin (2018-2023)
10.1.4 SynCardia Systems Artificial Heart Products Offered
10.1.5 SynCardia Systems Recent Development
10.2 BiVACOR
10.2.1 BiVACOR Company Information
10.2.2 BiVACOR Introduction and Business Overview
10.2.3 BiVACOR Artificial Heart Sales, Revenue and Gross Margin (2018-2023)
10.2.4 BiVACOR Artificial Heart Products Offered
10.2.5 BiVACOR Recent Development
10.3 CARMAT
10.3.1 CARMAT Company Information
10.3.2 CARMAT Introduction and Business Overview
10.3.3 CARMAT Artificial Heart Sales, Revenue and Gross Margin (2018-2023)
10.3.4 CARMAT Artificial Heart Products Offered
10.3.5 CARMAT Recent Development
10.4 Abbott
10.4.1 Abbott Company Information
10.4.2 Abbott Introduction and Business Overview
10.4.3 Abbott Artificial Heart Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Abbott Artificial Heart Products Offered
10.4.5 Abbott Recent Development
10.5 Cleveland Heart
10.5.1 Cleveland Heart Company Information
10.5.2 Cleveland Heart Introduction and Business Overview
10.5.3 Cleveland Heart Artificial Heart Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Cleveland Heart Artificial Heart Products Offered
10.5.5 Cleveland Heart Recent Development
10.6 AbioMed
10.6.1 AbioMed Company Information
10.6.2 AbioMed Introduction and Business Overview
10.6.3 AbioMed Artificial Heart Sales, Revenue and Gross Margin (2018-2023)
10.6.4 AbioMed Artificial Heart Products Offered
10.6.5 AbioMed Recent Development
10.7 Jarvik Heart
10.7.1 Jarvik Heart Company Information
10.7.2 Jarvik Heart Introduction and Business Overview
10.7.3 Jarvik Heart Artificial Heart Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Jarvik Heart Artificial Heart Products Offered
10.7.5 Jarvik Heart Recent Development
10.8 MyLVAD
10.8.1 MyLVAD Company Information
10.8.2 MyLVAD Introduction and Business Overview
10.8.3 MyLVAD Artificial Heart Sales, Revenue and Gross Margin (2018-2023)
10.8.4 MyLVAD Artificial Heart Products Offered
10.8.5 MyLVAD Recent Development
10.9 Cirtec Medical Systems
10.9.1 Cirtec Medical Systems Company Information
10.9.2 Cirtec Medical Systems Introduction and Business Overview
10.9.3 Cirtec Medical Systems Artificial Heart Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Cirtec Medical Systems Artificial Heart Products Offered
10.9.5 Cirtec Medical Systems Recent Development
10.10 Thoratec Corporation
10.10.1 Thoratec Corporation Company Information
10.10.2 Thoratec Corporation Introduction and Business Overview
10.10.3 Thoratec Corporation Artificial Heart Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Thoratec Corporation Artificial Heart Products Offered
10.10.5 Thoratec Corporation Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Artificial Heart Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Artificial Heart Industrial Chain Analysis
11.4 Artificial Heart Market Dynamics
11.4.1 Artificial Heart Industry Trends
11.4.2 Artificial Heart Market Drivers
11.4.3 Artificial Heart Market Challenges
11.4.4 Artificial Heart Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Artificial Heart Distributors
12.3 Artificial Heart Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
